Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risk » significant role (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risk » significant role (Expand Search)
-
2221
-
2222
-
2223
-
2224
Recruitment flow diagram of the current study.
Published 2025“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
-
2225
-
2226
-
2227
-
2228
-
2229
-
2230
-
2231
-
2232
-
2233
-
2234
-
2235
-
2236
Data extracted from included studies for the systematic review and meta-analysis.
Published 2025Subjects: -
2237
Specifications and outcomes of clinical trial studies included in the meta-analysis.
Published 2025Subjects: -
2238
-
2239
-
2240
Modelled seroprevalence estimates (coloured regions) compared with real data (black).
Published 2024Subjects: